| 455 | 25 | 105 |
| 下载次数 | 被引频次 | 阅读次数 |
目的探讨不同控制性卵巢刺激(COS)方案对早发性卵巢功能不全(POI)患者获卵数和可用胚胎数的影响。方法回顾性分析2016年1月至2019年3月在我中心行IVF-ET治疗的184例POI患者,共行431个取卵周期。根据COS方案不同分为拮抗剂方案(n=121)、自然周期(n=55)、克罗米芬(CC)+促性腺激素(Gn)方案(n=149)、口服避孕药(OC)+Gn方案(n=60)、长方案(n=22)、超短方案(n=24)。采用广义估计方程(generalized estimating equation,GEE)分析的方法,探讨不同COS方案对POI患者获卵数和可用胚胎数的影响。结果对各组基线资料进行比较,不同COS方案周期患者间的夫妻双方年龄、BMI、基础FSH水平均无统计学差异(P>0.05);各组间基础窦卵泡数和AMH水平比较差异具有统计学意义(P<0.05)。拮抗剂方案、自然周期、CC+Gn方案、OC+Gn方案、长方案、超短方案的获卵数分别为(2.69±1.78)、(0.89±0.46)、(1.42±1.13)、(1.65±1.62)、(3.32±2.10)和(1.92±1.44)个,可用胚胎数分别为(1.24±1.15)、(0.44±0.54)、(0.55±0.74)、(0.72±0.90)、(1.55±1.63)和(0.96±1.08)个,可用胚胎率分别为(0.62±0.44)%、(0.45±0.50)%、(0.43±0.48)%、(0.43±0.46)%、(0.60±0.42)%和(0.54±0.49)%,组间差异均具有统计学意义(P<0.05)。进一步行多因素分析,自然周期、CC+Gn周期和OC+Gn周期的获卵数、MⅡ卵数及可用胚胎数显著少于拮抗剂方案(P<0.05)。结论对于POI患者,拮抗剂方案、长方案和超短方案可以获得相近的可用胚胎数,其中拮抗剂方案是第一选择方案,建议临床推广。对于自然周期、CC+Gn方案、OC+Gn方案在POI患者中的应用,仍然需要进一步探索。
Abstract:Objective:To explore the outcomes of different control ovarian stimulation(COS) protocols in patients with premature ovarian insufficiency(POI).Methods:A retrospective analysis was performed on 184 POI patients treated by IVF-ET in our center from January 2016 to March 2019,with a total of 431 oocytes retrieval cycles. According to the different COS protocols,the patients were divided into antagonist protocol(n=121),natural cycle protocol(n=55),clomiphene(CC) + gonadotropin(Gn) protocol(n=149),oral contraceptive protocol(OC) + Gn protocol(n=60),long protocol(n=22),ultra-short protocol(n=24). The influence of different COS protocols on the number of oocytes retrieval and available embryos in POI patients was investigated by generalized estimation equation(GEE).Results:The baseline data of each group were compared. There was no significant difference in age,BMI and basal FSH level among the patients with different COS protocols(P>0.05). However,the number of basal antral follicles and AMH level were significantly different among the groups(P<0.05). The number of oocytes retrieval in antagonist protocol,natural cycle protocol,clomiphene plus Gn protocol,OC+Gn protocol,long protocol,ultra-short protocol was(2.69±1.78)、(0.89±0.46),(1.42±1.13),(1.65±1.62),(3.32±2.10) and(1.92±1.44) respectively;the number of available embryos was(1.24±1.15),(0.44±0.54),(0.55±0.74),(0.72±0.90),(1.55±1.63) and(0.96±1.08),respectively;and the available embryo rate was(0.62±0.44)%,(0.45±0.50)%,(0.43±0.48)%,(0.43±0.46)%,(0.60±0.42)%,(0.54±0.49)% respectively,with significant differences(P<0.05). Further multi-factor analysis showed that the number of oocytes retrieved,the number of MⅡ oocytes and the number of available embryos in the natural cycle protocol,CC+Gn protocol and OC+Gn protocol were significantly less than that of the antagonist protocol(P<0.05).Conclusions:For patients with POI,the antagonist protocol,long protocol and ultra-short protocol can obtain a similar number of available embryos,of which the antagonist protocol is the first choice,and clinical promotion is recommended. The application of natural cycle,CC+Gn regimen,and OC+Gn protocol in POI patients still needs further exploration.
[1] 陈婉乐,刘玉东,李雪兰,等.早发性卵巢功能不全患者赠卵IVF获得妊娠在孕期合并系统性红斑狼疮:1例报告并文献复习[J].南方医科大学学报,2017,37:1683-1687.
[2] Falorni A,Minarelli V,Eads CM,et al.A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency[J].Panminerva Med,2014,56:245-261.
[3] 刘尧,饶坤颖.原发性卵巢功能不全的预测指标解析[J].现代医药卫生,2018,34:1351-1354.
[4] 李琳,闫论,闫慧慧,等.早发性卵巢功能不全的遗传学最新研究进展[J].中华生殖与避孕杂志,2018,38:416-420.
[5] 陈子江.生殖内分泌学[M].北京:人民卫生出版社,2016.
[6] Chen X,Chen SL,Ye DS,et al.Retrospective analysis of reproductive outcomes in women with primary ovarian insufficiency showing intermittent follicular development[J/OL].Reprod Biomed Online,2016,32:427-433.
[7] 唐瑞怡,陈蓉.早发性卵巢功能不全激素补充治疗[J].中国实用妇科与产科杂志,2018,34:261-265.
[8] 马媛,李懋,梁新新,等.不同位置子宫内膜息肉TCRP术后对IVF/ICSI妊娠结局的影响[J].生殖医学杂志,2017,26:1206-1211.
[9] 周晶,李博,陈书强,等.冻融胚胎与新鲜胚胎移植的新生儿结局比较[J].生殖医学杂志,2017,26:9-13.
[10] 华医学会生殖医学分会第一届实验室学组.人类体外受精-胚胎移植实验室操作专家共识(2016)[J].生殖医学杂志,2017,26:1-8.
[11] Balaban B,Brison D,Calderon G,et al.The Istanbul consensus workshop on embryo assessment:proceedings of an expert meeting[J/OL].Reprod Biomed Online,2011,22:632-646.
[12] 胡琳莉,黄国宁,孙海翔,等.CSRM指南共识的制定规范(2016)[J].生殖医学杂志,2017,26:289-301.
[13] Munch EM,Sparks AE,Zimmerman MB,et al.High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers[J].Hum Reprod,2017,32:1402-1409.
[14] 陈士岭,周星宇.早发性卵巢功能不全的临床诊治进展[J].山东大学学报(医学版),2018,56:1-7.
[15] 叶静,陈秋菊,匡延平.卵巢功能正常患者高孕激素状态下促排卵的内分泌特征及IVF/ICSI临床结局的研究[J].生殖与避孕,2015,35:393-400.
[16] 徐晓菲,王辉,张翊昕,等.高龄卵巢低反应患者体外受精-胚胎移植的不同促排卵方案分析[J].解放军医学院学报,2016,37:750-753.
[17] 杜晓果,杨蕊,陈新娜,等.口服避孕药预处理时间对预期卵巢低反应患者临床结局的影响[J].生殖医学杂志,2020,29:162-168.
[18] 曹蓓,李艳萍,刘冬娥,等.微刺激方案与常规促排卵方案在高龄卵巢低反应不育女性中的前后周期比较[J].生殖医学杂志,2014,23:709-713.
[19] 杨会生.针刺对早发性卵巢功能不全患者卵巢功能影响的病例注册登记研究[D].中国中医科学院,2019.
[20] 张学红,王丽艳.早发性卵巢功能不全促生育治疗[J].中国实用妇科与产科杂志,2018,34:258-261.
基本信息:
中图分类号:R714.8
引用信息:
[1]杨弘睚,马媛,石永乾,等.不同控制性卵巢刺激方案对早发性卵巢功能不全患者获卵数和可用胚胎数的影响[J].生殖医学杂志,2020,29(10):1280-1286.
基金信息:
唐都医院科里创新发展基金(2017LCYJ018)
2020-10-15
2020-10-15